Jan Adams
Supervisory Board
Topas Therapeutics
Germany
Biography
Jan Adams is a Managing Director with EMBL Ventures, focusing on opportunities in the drug development sector. He has been representing the firm on various portfolio boards, e.g., Lipid Therapeutics, Opsona, Arsanis and ViraTherapeutics. Prior to joining EMBL Ventures, Jan was a postdoctoral Fellow of the Ernst Schering Research Foundation at the University of Granada, Spain. Before that he was a Fellow of the Boehringer Ingelheim Research Foundation, conducting work on molecular transport mechanisms at the Wellcome CRC in Cambridge, UK. Jan holds a M.S. in Biochemistry & Molecular Biology from Tübingen University, Germany and completed a PhD in Genetics at the University of Cambridge, UK.
Research Interest
Biochemistry and Molecular Biology
